The relationship between the severity of the mutations and pancreatic damage has been previously reported by grouping the mutations into classes, associating a higher risk of pancreatic insufficiency in those with variants that cause greater CFTR dysfunction [50–53]. The gene discussed is CFTR; the disease is exocrine pancreatic insufficiency.